UPCC 11908 Registry and Biosample Repository

Registry and Biosample Repository in Patients Undergoing Radiotherapy

Enrolling By Invitation
18 years or above
All
Phase N/A
8000 participants needed
1 Location

Brief description of study

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Neoplasia
  • Age: 18 years or above
  • Gender: All

  • Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
    • Able to sign consent

This study investigates the creation of a registry and biosample repository for patients diagnosed with cancer or benign tumors who are undergoing radiotherapy. A biosample repository includes biological samples such as blood, urine, and tumor specimens, which are collected and stored for research purposes.

Participants in this study will have their blood, urine, and tumor samples collected while they undergo their routine radiotherapy treatment. These samples will be stored in a repository to help researchers understand more about cancer and benign tumors.

  • Who can participate: Individuals aged 18 and above with a diagnosis of cancer or benign tumors who are undergoing radiotherapy can participate. Participants must be able to sign consent.
  • Study details: Participants will provide blood, urine, and tumor samples during their radiotherapy treatment. These samples will be used for research purposes and stored in a biosample repository.
Updated on 28 Jul 2026. Study ID: 22-1041
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator